Expand CLDX Menu
CLDX MENU

CLDX Stock Posts


Unusual Option Volume

CLDX Celldex Therapeutics35.30-2.59 (-6.8%)

Celldex Therapeutics trades 2,366 contracts. The company has the following event: Celldex Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Results Conference Call/Webcast on Sep 22, 2026. News: Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
View Details...
CLDX #CelldexTherapeutics stock declines -6.6% in premarket,

Premarket Decliner

CLDX Celldex Therapeutics37.89-0.35-0.9%

Premarket:35.38-2.51 (-6.6%)

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

Globe NewswireTue, 22-Sep 6:58 AM
Unusual Option Volume

CLDX Celldex Therapeutics39.53+0.82 (+2.1%)

Celldex Therapeutics trades 3,040 contracts. The highest volume is in the 16-Oct-26 38 puts.
View Details...
Unusual Option Volume

CLDX Celldex Therapeutics38.07+1.17 (+3.2%)

Celldex Therapeutics trades 4,051 contracts.
View Details...
CLDX #CelldexTherapeutics stock declines -7.1% in after hours trading. See the latest news.

After Hours Decliner

CLDX Celldex Therapeutics35.66+0.24+0.7%

After Hours:33.14-2.52 (-7.1%)

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis

Globe NewswireTue, 21-Jul 4:01 PM
CLDX #CelldexTherapeutics stock declines -3.5% in after hours trading. See the latest news.

After Hours Decliner

CLDX Celldex Therapeutics31.26-0.46-1.5%

After Hours:30.18-1.08 (-3.5%)

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

Globe NewswireWed, 1-Apr 9:48 PM
Load Earlier Posts
Market Data Delayed 15 Minutes